New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Australia: Stroke rates decline, but many still preventable
The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.
Cardiology
May 16, 2013 |
not rated yet |
0
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
